Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126900191 | 12690019 | 1 | I | 201306 | 20160823 | 20160826 | 20160826 | EXP | US-ASTELLAS-2016US032910 | ASTELLAS | 64.41 | YR | F | Y | 0.00000 | 20160826 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126900191 | 12690019 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Unknown | 21743 | 100 | MG | TABLET | QD | |||||||
126900191 | 12690019 | 2 | SS | Erlotinib | ERLOTINIB | 1 | Oral | 83093P1CW | 21743 | 75 | MG | TABLET | QD | ||||||
126900191 | 12690019 | 3 | SS | Erlotinib | ERLOTINIB | 1 | Unknown | UNK, UNKNOWN FREQ. | 21743 | TABLET | |||||||||
126900191 | 12690019 | 4 | SS | Erlotinib | ERLOTINIB | 1 | Unknown | 21743 | 150 | MG | TABLET | QD | |||||||
126900191 | 12690019 | 5 | SS | MORPHINE | MORPHINE | 1 | Unknown | UNK, UNKNOWN FREQ. | 0 | FORMULATION UNKNOWN | |||||||||
126900191 | 12690019 | 6 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
126900191 | 12690019 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
126900191 | 12690019 | 8 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
126900191 | 12690019 | 9 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | 5 | MG | TABLET | |||||||
126900191 | 12690019 | 10 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | U | 0 | 20 | MG | TABLET | |||||||
126900191 | 12690019 | 11 | C | RANITIDINE HCL | RANITIDINE HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
126900191 | 12690019 | 12 | C | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
126900191 | 12690019 | 13 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126900191 | 12690019 | 1 | Non-small cell lung cancer |
126900191 | 12690019 | 2 | Lung neoplasm malignant |
126900191 | 12690019 | 5 | Cancer pain |
126900191 | 12690019 | 6 | Chronic obstructive pulmonary disease |
126900191 | 12690019 | 7 | Product used for unknown indication |
126900191 | 12690019 | 8 | Product used for unknown indication |
126900191 | 12690019 | 9 | Product used for unknown indication |
126900191 | 12690019 | 10 | Product used for unknown indication |
126900191 | 12690019 | 11 | Product used for unknown indication |
126900191 | 12690019 | 12 | Product used for unknown indication |
126900191 | 12690019 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126900191 | 12690019 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126900191 | 12690019 | Constipation | |
126900191 | 12690019 | Death | |
126900191 | 12690019 | Diarrhoea | |
126900191 | 12690019 | Fatigue | |
126900191 | 12690019 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126900191 | 12690019 | 2 | 20130505 | 0 | ||
126900191 | 12690019 | 3 | 201306 | 0 | ||
126900191 | 12690019 | 4 | 201507 | 0 |